1. Home
  2. NRXP vs CLIR Comparison

NRXP vs CLIR Comparison

Compare NRXP & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • CLIR
  • Stock Information
  • Founded
  • NRXP 2015
  • CLIR 2008
  • Country
  • NRXP United States
  • CLIR United States
  • Employees
  • NRXP N/A
  • CLIR N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • CLIR Industrial Machinery/Components
  • Sector
  • NRXP Health Care
  • CLIR Industrials
  • Exchange
  • NRXP Nasdaq
  • CLIR Nasdaq
  • Market Cap
  • NRXP 51.3M
  • CLIR 59.3M
  • IPO Year
  • NRXP N/A
  • CLIR 2012
  • Fundamental
  • Price
  • NRXP $2.28
  • CLIR $0.80
  • Analyst Decision
  • NRXP Strong Buy
  • CLIR Strong Buy
  • Analyst Count
  • NRXP 3
  • CLIR 1
  • Target Price
  • NRXP $31.67
  • CLIR $6.00
  • AVG Volume (30 Days)
  • NRXP 464.9K
  • CLIR 94.9K
  • Earning Date
  • NRXP 03-27-2025
  • CLIR 03-31-2025
  • Dividend Yield
  • NRXP N/A
  • CLIR N/A
  • EPS Growth
  • NRXP N/A
  • CLIR N/A
  • EPS
  • NRXP N/A
  • CLIR N/A
  • Revenue
  • NRXP N/A
  • CLIR $4,280,000.00
  • Revenue This Year
  • NRXP N/A
  • CLIR $69.16
  • Revenue Next Year
  • NRXP N/A
  • CLIR $440.76
  • P/E Ratio
  • NRXP N/A
  • CLIR N/A
  • Revenue Growth
  • NRXP N/A
  • CLIR 263.02
  • 52 Week Low
  • NRXP $1.10
  • CLIR $0.62
  • 52 Week High
  • NRXP $7.33
  • CLIR $1.72
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 38.85
  • CLIR 27.40
  • Support Level
  • NRXP $2.80
  • CLIR $0.81
  • Resistance Level
  • NRXP $3.07
  • CLIR $1.06
  • Average True Range (ATR)
  • NRXP 0.29
  • CLIR 0.09
  • MACD
  • NRXP -0.10
  • CLIR -0.03
  • Stochastic Oscillator
  • NRXP 2.52
  • CLIR 2.38

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About CLIR ClearSign Technologies Corporation (DE)

ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.

Share on Social Networks: